Explaination of New Guideline for Post-approval Changes to Chemical Drug in Combination with the Post-approval Change Managements in China, the United States and Europe

被引：0
|
作者：
Zhang, Baomei [1 ]
Lu, Xiaojun [1 ]
机构：
[1] Center for Drug Evaluation, National Medical Products Administration, Beijing,100022, China
来源：
Chinese Journal of Pharmaceuticals | 2022年 / 53卷 / 07期
关键词：
D O I：
10.16522/j.cnki.cjph.2022.07.020
中图分类号：
学科分类号：
摘要：
7
引用
收藏
页码：1056 / 1061
相关论文
共 50 条
  • [41] Impact Assessment of Divergence on Post-approval Changes Classifications of Latin America Region With Europe and the United States, and Propositions to Harmonize Classification Based on Risk as a Path to Build the Trust Between National Regulatory Agencies
    Lucia, Maria Lucia De
    Comesana, Christian
    Rodriguez, Heraclio
    Dangy-Caye, Agnes
    CLINICAL THERAPEUTICS, 2024, 46 (02) : 164 - 172
  • [42] Analysis of the Regulatory Divergence of Comparative Dissolution Requirements for Post-Approval Manufacturing Changes of Modified Release Solid Oral Dosage Forms
    Langer, Connie
    Diaz, Dorys Argelia
    Van Alstine, Leslie
    Bandi, Nagesh
    Fitzgerald, Sarah
    Colgan, Stephen
    AAPS JOURNAL, 2020, 22 (01):
  • [43] Analysis of the Regulatory Divergence of Comparative Dissolution Requirements for Post-Approval Manufacturing Changes of Modified Release Solid Oral Dosage Forms
    Connie Langer
    Dorys Argelia Diaz
    Leslie Van Alstine
    Nagesh Bandi
    Sarah Fitzgerald
    Stephen Colgan
    The AAPS Journal, 22
  • [44] Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers
    Dellepiane, Nora
    Pagliusi, Sonia
    Akut, Prashant
    Comellas, Sebastian
    De Clercq, Norbert
    Ghadge, Shubhangi
    Gastineau, Thierry
    McGoldrick, Mic
    Nurnaeni, Ida
    Scheppler, Lorenz
    VACCINE: X, 2020, 6
  • [45] Path Forward to Optimise Post-approval Change Management and Facilitate Continuous Supply of Medicines and Vaccines of High Quality WorldwideJoint Position from EFPIA, IFPMA and Vaccines Europe
    Andrew Deavin
    Sarah Adam
    Susanne Ausborn
    Ane Sofie Böhm Nielsen
    Sonia Cappellini
    Isabelle Colmagne-Poulard
    Thierry Gastineau
    Arturo Gonzalez-Martinez
    Sylvie Meillerais
    Charlie Mortazavi
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 7 - 11
  • [46] Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: post-approval clinic experience
    Kasi, Anup
    McGinnis, Timothy
    Naik, Gurudatta
    Handa, Shivani
    Williams, Grant
    Paluri, Ravi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (02) : 464 - +
  • [47] Evolution of China regulatory guidance on the clinical evaluation of medical devices and its implication on pre-market and post-approval clinical evaluation strategies
    Su, Gui
    Deng, Dongyuan
    EXPERT REVIEW OF MEDICAL DEVICES, 2023, 20 (03) : 167 - 178
  • [48] Path Forward to Optimise Post-approval Change Management and Facilitate Continuous Supply of Medicines and Vaccines of High Quality Worldwide Joint Position from EFPIA, IFPMA and Vaccines Europe
    Deavin, Andrew
    Adam, Sarah
    Ausborn, Susanne
    Nielsen, Ane Sofie Bohm
    Cappellini, Sonia
    Colmagne-Poulard, Isabelle
    Gastineau, Thierry
    Gonzalez-Martinez, Arturo
    Meillerais, Sylvie
    Mortazavi, Charlie
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (01) : 7 - 11
  • [49] The association between concerns toward adverse reactions during pre-approval drug reviews and the post-approval addition of clinically significant adverse reactions to package inserts: A retrospective analysis of pre-approval drug review reports and safety updates
    Watanabe, Ko
    Murakami, Masayasu
    Masuyama, Koichi
    Ishiguro, Chieko
    Matsuda, Tsutomu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (11) : 1265 - 1276
  • [50] No change in avilamycin (Surmax® Premix) minimum inhibitory concentration for Clostridium perfringens isolates recovered from poultry up to 7 years post-approval in Canada
    Simjee, Shabbir
    Gould, George
    Maduro, Lila
    Boulianne, Martine
    Pridmore, Andrew
    Parent, Eric
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (05) : 1278 - 1281
12345